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Abstract. Using histochemical detection, we have
visualized in situ the complete metabolic pathway for
the degradation of purine nucleotides. From the tongue
to the ileum, diverse epithelial cell types lining the lu-
men of the mouse gastrointestinal (GI) tract strongly
coexpress each of the five key purine catabolic en-
zymes. Dramatic increases in the expression of each
enzyme occurred during postnatal maturation of the
GI tract. Using in situ hybridization, an intense ac-
cumulation of adenosine deaminase (ADA) mRNA was
detected only within GI epithelial cells undergoing post-
mitotic differentiation. In a similar manner, at the de-
veloping maternal-fetal interface, high level expression
of the purine catabolic pathway also occurred in a
unique subset of maternal decidual cells previously
known to express high levels of alkaline phosphatase
P
URINE nucleotide synthesis anddegradation areessen-
tial for life. Genetic defects in the purine metabolic
pathwaycancausedevastating humandisease, suchas
Lesch-Nyhan syndrome or severe immunodeficiency (Gib-
lett, 1972; Camera and Carson, 1987; Kredich and Hersh-
field, 1989). The importance ofthe purine pathway is also
illustrated by the wide variety of potent and clinically ben-
eficial drugs such as allopurinol, 6-mercaptopurine, metho-
trexate, andtrimethoprim thathaveresulted frompharmaco-
logical targeting ofpurine pathway enzymes (for review, see
Elion, 1989). Thepurine ring, large quantities ofwhich are
required for cell growth and proliferation, requires for its
synthesis more than a dozen enzyme activities, a spectrum
ofmetabolic substrates, and a substantial amount ofchemi-
cal energy.
Given the metabolic expense of purine biosynthesis, it
might be considered surprising that mice and other mam-
mals do not reuse dietary purine nucleotides for DNA and
RNA synthesis (SonodaandTatibana, 1978; Hoetal., 1979;
Savaiano et al., 1980; Uauy, 1989). Consistent with this, rat
duodenal mucosa has long been shown to produce the non-
reusablepurines, uric acid andallantoin, from AMP(Getler
Address correspondence to Dr. Aronow.
© The Rockefeller University Press, 0021-9525/91/10/179/12 $2.00
The Journal of Cell Biology, Volume 115, Number 1, October 1991 179-190
and ADA. This induction occurred almost immediately
after implantation in the periembryonic maternal decid-
ual cells, shortly thereafter in antimesometrial decidual
cells, and later in cells ofthe placental decidua basalis:
all of which contain cell types thought to be undergo-
ing programmed cell death. The expression ofthe path-
way at the site of embryo implantation appears to be
critical because its pharmacologic inhibition during
pregnancy has been found to be embryolethal or terato-
genic. Purine destruction at these nutritional interfaces
(placenta and gastrointestinal tract) seem to override
any potential economy ofpurine salvage, and may rep-
resent biochemical adaptation to nucleic acid break-
down occurring in the context of dietary digestion or
extensive programmed cell death.
et al., 1949; Wilson andWilson, 1962; Berlin andHawkins,
1968). However, although the enzymatic properties of in-
dividual purine catabolicenzymeshavebeenwellcharacter-
ized, and the localization of several of them has been de-
scribed(Sackler, 1966; Chechiketal., 1983; Chinsky etal.,
1990), the ability ofthe enzymes to function together in a
tissue- and cell type-specific manner has not been studied.
During previous studies of human adenosine deaminase
(ADA)' gene regulatory elements in transgenic mice (Aro-
now et al., 1989) we notedthe profound degree ofpostnatal
upregulation of the endogenous mouse ADA gene (Lee,
1973; Chinsky et al., 1990), and among several tissues in
the ppstimplantation reproductive tract (Knudsen et al.,
1988). Some ofthesetissues are not sites ofhigh-level ADA
expression inhumans and this ledus to question the role of
ADA expression in these locations. Specifically, humans ex-
press ADA athigh levels in the duodenum and thymus, but
at much lower levels in most other tissues including tongue
1. Abbreviations usedin thispaper: ADA, adenosine deaminase; AP, alka-
line phosphatase; dCF, 2' deoxycoformycin; CAT, chloramphenicol acetyl-
transferase; 5NT; 5'-nucleotidase; GI, gastrointestinal; GUAase, guanase;
NBT, nitrobluetetrazolium; p.c., post-coitus; PMS, phenazinemethane sul-
phonate; PNP, purine nucleoside phosphorylase; UA, uric acid; XO, xan-
thine oxidase.
179andesophagus (Aronowet al., 1989). In mice, ADA expres-
sion occurs in a somewhat similarpatternbutvery high-level
expression also occurs in tongue, esophagus, forestomach,
and placenta. The level of ADA expression in human pla-
centa is not known to be high, butthe placentas of rat, cat,
cow, guinea pig, and rabbit have been reported to contain
very high levels of ADA at some stages of gestation (Brady
and O'Donovan, 1965; Sim and Maguire, 1970).
Developmental studieshave also provided clues as to why
ADA is expressedat high levelin some locations. Lee (1973)
hasshownthat theactivities of ADA, xanthine oxidase (XO),
anduricase increase dramatically during thepostnatal matu-
ration of the stomach and duodenum in mice (Lee, 1973).
However, the cell types involved were neither identified nor
were the threeotherenzymesmeasured that wouldbe neces-
sary to complete the metabolic pathway (5'-nucleotidase [5'
NT], purine nucleoside phosphorylase (PNP), and guanase
[GUAase]). In the presentstudy, we demonstratethat theen-
tire series ofpurine catabolicpathwayenzymesareexpressed
in the same cell types and undergo developmentalcoregula-
tion in theproximal gastrointestinal tract. Moreover, we have
shownin situ that the enzymes function together in alinked
fashion. We also observe a similar coexpression of purine
catabolicenzymesin adistinct population ofcellsofthepost-
implantation maternal decidua long been known to express
high levels of 5'-nucleotidase alkaline phosphatase (Finn,
1971; Hall, 1971) and more recently ADA (Knudsen et al.,
1988, 1991). Like the mature gastrointestinal tract, a sub-
stantial subset of cells in the reproductive tract also appears
committed to the degradation of purine nucleotides.
Materials and Methods
Animals, T1ssues, andMaterials
(C57B1/6 X C3H) F1 mice were fed Purina 5001 chow (23.5% protein,
6.5 % fat; RalstonPurina Laboratories, St. Louis, MO)ad lib.Noon on the
day of vaginal plug appearance was designated day 0.5 post-coitus (p.c.).
Mice were killed by cervical dislocation immediately before collecting tis-
suesamples. Humantissue samples were culled from discarded adult and
pediatricbiopsy specimensinaccord with Institutional Review Boardguide-
lines. Enzymes and purine compounds were the highest quality available
from Sigma Chemical Co. (St. Louis, MO). Purine compounds were
analyzed by meansofHPLC (see below) with theeffluent monitoredat 254
nm. All were found to be >99% pure.
Enzyme and mRNA Quantitation
The specific activity of ADA was determined using total soluble extracts
(Wiginton, 1981). Homogenates were made in -20volof 0.1 M KHP04,
sonicated, andcentrifuged for20 minat 15,000 g. Theabsolute quantities
ofADAmRNAin total cellularRNA(ChomczynskiandSacchi, 1987)were
determined by RNaseA protection, PAGE, and surface radioactivity mea-
surement (model 603 analyzer; Betagen, Waltham, MA) using internal
standardization with knownquantities of purified sense strand RNA, and
normalized permicrogramof total RNA as previously described (Aronow
et al., 1989)using atranscription vector made from thecDNAclonepADA
5-29 (Yeung et al., 1985).
HistochemicalDetectionofPurine CatabolicEnzymes
Tissuesforhistochemistry were fixedfor4hat 4°Cin PBScontaining 30 %
sucrose and 0.5% glutaraldehyde. This degree of fixation gave improved
histology compared to previous methods (Spencer et al., 1968; Knudsen
et al., 1988) without discernible effects upon the distribution or intensity
ofobserved stains.Histochemicalstaining forthepurine catabolicenzymes
wasperformedbased on modifications of theprocedure originally devised
forthedetection of ADA(Spencer et al., 1968; Knudsenet al., 1988). The
The Journal of Cell Biology, Volume 115, 1991
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Figure 1. Purine nucleotide catabolism andhistochemistry. (A)The
metabolic routes for the degradation of purine nucleotides are
summarized. When DNA and RNA are degraded by DNase and
RNaseA, 5' deoxynucleoside monophosphates and a mixture of 2'
and 3' nucleoside monophosphates are produced, respectively. In-
testinal AP andNT hydrolyzethephosphoryl esters,andtheresult-
ing nucleosides can be transported across plasma membranes and
actedupon by subsequent enzymes. In primates, XO is theterminal
step for purine catabolism, whereas most other mammals oxidize
UA to allantoin via uricase. XO activity renders the purine ring
non-reutilizable forpurine salvage. (B) Biochemical basis for the
histochemicallocalization of purine catabolicenzyme activities. To
localize any enzyme in the catabolic pathway (A), cocktails were
formulated in which the substrate for the desired enzyme is pro-
vided, then enzymes for the subsequent steps were supplemented
in the mix. Reducing potential generated by the oxidation of xan-
thine to uric acid causes in situ reduction of NBT to form a dark
blue formazan reaction product. 1h test for theconnectivity of all
ofthecatabolicenzymesin situ (5'NT-"XO), AMPis thesubstrate
and no exogenous enzymes are added.
terminal step for each histochemical reaction is the oxidation of hypoxan-
thine or xanthine by XO leading to the reductionof nitroblue tetrazolium
(NBT)to an insoluble blue formazan reaction product. Thecompositionof
each cocktail is described inthelegendto Fig. 1, wheretheindividual com-
ponents (whenincluded) arepresentat thefollowingconcentrations: NBT,
0.8 mM; AMP, 1 mM; inosine, 1 mM; guanine, 1 mM; PNP, 10 pg/ml;
phenazinemethanesulphonate (PMS), 0.15 mM; adenosine, 1 mM; hypo-
xanthine, 1 mM; ADA, 5 ug/ml; and XO, 0.07 U/ml.
All incubations were performed in 50 mM NaHP04 buffer pH 7.4 at
37°C for varying lengthsof time as indicated (15 minto 1 hin thedark).
Doingthisprovided aroughquantitative indexofenzymaticactivity as indi-
catedbytheintensity offormazan deposition. Sections were rinsed inwater
and cover-slips were applied using Aqua-Poly/Mount (Polysciences, Inc.,
Warrington, PA). Photographs were takenwithin 48 hto avoidaprominent
nuclear staining artifact that occurred upon prolonged storage. Forcontrol
experiments, to specifically inactivate ADA enzyme activity, adjacent sec-
tionswere incubated in 1 uM 2' deoxycoformycin for30 minat room tem-
perature. To specifically inactivate XO activity, sections were preincubated
with 1 mM oxypurinol for30 min. Tb observe the inhibitory effect ofoxy-
purinol, PMS had to be omitted which led to only a slight diminution in
the intensity andbrilliance of theblue formazan reaction product. The 30-
minpreincubation in theabsenceofstaindidnotimpair theintensity ofthe
subsequent staining reaction (not shown).
For in situ hybridization, unfixed tissue wasembedded in OCTcompound
(Miles Laboratories, West Haven, CT), snap frozen, cut at athicknessofc 5000 .iv
0
CM
E 500
C
E
0
E
.U
¢
0
50
5
0 .5
Results
TONGUE
PLACENTA
DUODENUM
ADA mRNA (pg/10pg total RNA)
Figure 2. Tissue-specific expression pattern ofADA mRNA and en-
zyme in adult mouse tissues. The specific activity of ADA was de-
termined using total soluble extracts, mRNA was quantitated by
RNase protection using "P-labeled probes made antisense to
mouse ADA mRNA and standardization to known quantities of
purified sense strand RNA and normalized per 1Ag of total RNA,
both as previously described (Aronow et al., 1989). Placental RNA
and enzyme extracts were obtained from the placenta of a day-16
pregnancy. Note that the graph is a double-log plot and that between
some tissues there are differences >1,000-fold. Data points from a
single set of experiments are shown, duplicate analyses of the ex-
tracts and RNAs have shown variations of 10-50% ofthe values that
are shown.
6 ,um, and fixed in4% paraformaldehyde in PBS for 1 min. Prehybridization
was carried out at room temperature for 0.25 h as previously described
(Aronow et al., 1989), except that prehybridization and hybridization solu-
tions were supplemented with 10 mM DTT and 0.1 mM alpha-thio-UTP.
The addition ofthese agents appeared to virtually eliminate the occurrence
of background and artifactual labeling by unrelated probes (not shown).
HPLCAnalysisofPurine Metabolites
Tissue portions (N50 mg) were incubated at 37°C in 1 ml ofa solution that
contained 25 mM NaPO4, pH 7.2, and 1 mM AMP. At the indicated times,
100 pl-aliquots were removed and added to an equal volume of ice-cold
10% TCA, incubated at4°C for Nl h, andcentrifuged at 15,000g for 3 min.
Supernatants were neutralized by extraction with an equal volume of tri-N-
octylamine/chloroform (22.78) and stored at -80°C. Purine compounds
were separated by HPLC on a Delta-Pak C-18 reverse-phasecolumn (Milli-
pore, Inc., Milford, MA) using50 mM ammonium fotmate, pH 4.35 (0.5 M
stockprepared by neutralization of0.5 M formic acid with concentrated am-
monium hydroxide) as the initial mobile phase for 10 min, with a gradient
to 100% methanol at 20 min. Uric acid (UA) (3.24 min), xanthine (4.21
min), hypoxanthine (3.73 min), inosine (11.58 min), adenosine (15.75 min),
and AMP (4.88 min) were quantitated by means of comparison of peak
areas (absorbance monitored at 254 mn) to that of known standards.
77ssue andCellType-specificADA Regulation
To ascertain the extent to which variation in ADA enzyme
activities among different mouse tissues is attributable to
variations in ADA mRNA accumulation, quantitative RNA-
ase protection assays were performed. As depicted in Fig. 2,
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there is a strong correlation of ADA enzyme levels with
mRNA levels over a 4-log range of tissue-specific ADA ex-
pression. Since the proximal GI tract and placenta are con-
siderably higher in ADA expression than other mouse tis-
sues, and there are striking species differences with respect
to expression from some of these sites, we reasoned that the
identification of the expressing cell types in these tissues
could provide clues to explain this interesting expression
pattern.
The cell types responsible for generating the high level of
ADA mRNApresent in totalRNA from the proximal GI and
reproductive tracts were identified by in situ hybridization.
As shown in Fig. 3, within the GI tract there was an intense
accumulation of ADA mRNA in a highly localized fashion
within a diverse set of maturing epithelial structures. In the
tongue, esophagus, and forestomach, ADA mRNAaccumu-
lation was confined to the superficial layers ofthe squamous
epithelium with little or no signal present in the more imma-
ture basal layers (Fig. 3, A-G). The duodenal mucosa
showed a gradient of signal that was highest in the villous
tips, lower around the villous base, and virtually absent in
the crypts. This pattern of expression was completely
recapitulated by histochemical staining specific for ADA ac-
tivity (Chinsky et al ., 1990; ourselves, not shown). Because
villous epithelial cells are derived from mitoses that occur
in the crypts, and squamous epithelial cells are derived by
maturationfrom basal cell mitoses (for review see Potten and
Hendry, 1983 ; Gordon, 1989), ADA gene expression to
form ADA mRNA must be subject to stringent regulation
during the postmitotic maturation of these cells. From duo-
denum to terminal ileum, each of the small bowel segments
that we have examined exhibited similar crypt to villous gra-
dients of ADA mRNA. However, the distal small bowel ex-
hibited less total signal, consistent with results of RNAase
protection assays showing ADA mRNAto be present in total
RNA from the distal ileum at 25-50% of its relative abun-
dance in total RNA isolated from duodenum (not shown).
We have also observed high-level ADA mRNA and en-
zyme accumulation at several stages of placental develop-
ment within decidual and cytotrophoblastic tissue (Fig. 3,
H-J), in general agreement with immunohistochemical
results of Knudsen et al. (1988, 1991). The specific cell types
that are responsible will be described below. A variety of
other adult and fetalmouse tissues have also been evaluated.
Histochemical staining and in situ hybridization of lung,
uterus, cervix, colon, skin, brain, pancreas, lymph nodes,
and spleen failed to reveal any restricted cell types that ac-
cumulate a high level of enzyme or mRNA (not shown).
Thus, since ADA expression does not occur at high level in
epithelial or placental cell types that are morphologically
quite similar to the expressing cell types, there appears to
be strong regional specificity to ADA's expression in the GI
tract and placenta.
To consider the potential function of high-level ADA ex-
pression in the GI tract and placenta, it is important to note
that ADA performs a central step in purine catabolism (Fig.
1 A), allowing for either purine salvage via hypoxanthine
phosphoribosyl transferase or purine degradation via XO.
Salvage and degradation ofGMP uses several ofthe same en-
zymes, with the additional requirement for GUAase activity
in degradation. If the deamination of adenosine or deoxy-
adenosine by ADA was essential for regulating local concen-Figure 3 In situ hybridization for
the localization ofADAmRNA in
adult mouse tissues . 35S-labeled
antisense RNA probes were hy-
bridized as previously described
(Aronow et al ., 1989) to cryostat
sections of mouse tongue, esopha-
gus, stomach, duodenum, and pla-
centa . Silver grains appear blackin
the brightfield (A, B, D, G, and
H) andwhite inthe darkfield (C, E,
F, and I) views . Highly localized
signal is evident in the squamous
epithelium lining the tongue (A),
esophagus (B and C), forestomach
(D and E), and in the epithelial
cells located at the tips of the villi
in theduodenum (Fand G) . In the
stomach there is a strong signal in
the squamous epithelium of the
forestomach but a much lower sig-
nal in the glandular mucosa (D
andE) . Note the absence of signal
over germinal epithelial cells in the
tongue, esophagusandforestomach
(A-D) . The duodenum shows in-
tense signal in the epithelial cells
lining the villous tips (VT) and no
signal in the laminapropria (LP) or
the epithelial cells towards the base
of the villi or in the crypts . Strong
signal is evident in decidualized
reproductive tract cells at distinct
stages of gestation (H-J) . At day 9
(H), there is a massive accumula-
tion ofADAmRNA in the decidual
capsularis (DC) cells, present
along the antimesometrial (Am)
side of the uterus . In the day 16
placenta (I and J) strong signal is
present in the spongiotrophoblastic
layer (Sl) and decidua basalis (DB),
but not in the chorioallantoic plate
(CA) . J is a section of a 16-d pla-
centa fixed in Bouin's solution and
embedded in paraffin to show better
detail of these layers and additional
components (yolk-sac membrane,
I'm, myometrium, my ; decidua ba-
salislmetrial gland;(DB/MG) . The
plane of I is parasagital to the cen-
trally localized metrial gland . In
separate experiments, no signal
was detected in mouse skin or in re-
spiratory, colonic, or cervical mu-
cosa with ADAprobe, and no sig-
nal was detected in any of the above
tissues when probed with the sense
strand of mouse ADA mRNA, a
control probe antisense to bacterial
CATmRNA,or to the sense strands
ofa variety of other cDNA probes .
Slides were exposed for 48-72 h .
Bars, 50 Am .Figure 4 . Histochemical analyses
of catabolic enzymes in situ . Tis-
sue sections were stained for either
individual purine catabolic enzyme
activities, or theentire purine cata-
bolic pathway as described in Ma-
terials and Methods (see Fig . 1) .
Each ofthecell types that exhibited
strong signal by in situ hybridiza-
tion versus ADA mRNA also ex-
hibits high-level expression ineach
purine catabolic enzyme andthese
enzymes function in situ in a linked
fashion. The tissues and the in-
dividual enzyme activities, or en-
zyme pathway activities, that are
illustrated in this figure are as fol-
lows : (A) mouse tongue PNP, (B)
mouseesophagusPNP, (C)mouse
stomachXO, (D) mouseduodenum
5NT -+ XO, (E) mouseduodenum
5NT - XO preincubated with
dCF, (F) mouse duodenum 5NT
--" XO preincubated with oxypuri-
nol, (G) term-fetal mouse duode-
num 5NT -" XO, (H) post-natal
day 5 mouse duodenum 5NT
XO, (I) human duodenum ADA,
(J) humanduodenum5NT-"XO,
(K) mouseduodenum XO, (L) day
6.5 mouse implantation site 5NT
XO, (M) day6.5 mouseimplan-
tation site stained with hematoxy-
linandeosin, and(N)day 16 mouse
placenta XO. In themouse tongue,
esophagus, and forestomach, the
blue formazan reaction product
localizes to the mature surface
squamous epithelial cells. The api-
cal and basalar limits ofthe villous
enterocytes are demarcated by ar-
rowheads in I-K. Note the strongly
sublocalized reaction in the brush
border region ofthe cells and in ad-
dition in a granular pattern at the
basalar portion of the enterocytes.
At the mouse implantation site (L
andM) note that only the decidual
cells immediately adjacent to the
embryo express the purine cata-
bolicenzymes strongly. In the ma-
ture placenta (N) XO and each of
the catabolicenzymes are localized
to thedecidua basalis (DB), and spongiotrophoblast (ST) with little or no activity within the chorioallantoic plate (CA) or in the uterine
myometrial wall (arrowhead) . The results of these and other histochemical analyses are summarized in Table 1 . Bars, 50 am.
trations of adenosine, salvage might be expected . Alterna-
tively, if high-levelADAexpression were part ofametabolic
pathway leading to the net breakdown to nonreusable com-
pounds, localizedcoexpression ofXO andGUAase mightbe
expected .
Histochemical Demonstration ofPurine Catabolic
EnzymesandtheirFunctional Linkage In Situ
One approach to distinguishing among the above possibili-
ties for tissue-specific ADA function is to evaluate the rela-
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tive expression of other enzymes in the purine catabolic
pathway within specific types of cells . To do this, we modified
standard histochemical techniques (Spencer et al ., 1968 ;
Knudsen et al ., 1988) to allow the detection of each of the
enzymes ofthepurine catabolicpathway. Cocktailswere de-
vised to demonstratethe activity of each enzyme (Fig . 1 B) .
We further sought to modify this approach to demonstrate
that the product of one enzymatic step could efficiently pro-
vide substrate for the next, in situ . Thepotential of this ap-
proach is that an entire metabolic pathway, with a series of
183Figure 4 (continued) .
individual enzymes, could be demonstrated in situ . To do
this for the complete purine catabolic pathway, AMP and
NBT were used as the substrates without the addition of ex-
ogenous enzymes to the cocktail .
The results ofthese studies are shown in part in Fig . 4, and
summarized in Table I, and indicate that each ofthe catabolic
enzymes (SNT, ADA, PNP, XO, and GUAase) is present in
the same cell types within the proximal GI tract (Fig . 4, A-K,
Table I) . Table I indicates only the relative intensities of the
staining reactions, and should not be construed as strict
quantitative measures of the amount ofenzyme present . For
each tissue examined there was complete concordance with
results that were obtained by in situ hybridization for ADA
mRNA . Specifically, the great majority of the differentiated
mucosal epithelial cells of the tongue, esophagus, fore-
stomach, and duodenum exhibited intense expression of
each of the five enzyme activities that were tested . A strong
signal was also detected when the complete purine catabolic
pathway was tested indicating that the enzymes were also
able to function in a linked fashion in situ .
In all tissue sections that we have analyzed, for each site
of high-level ADA expression, the omission of purine sub-
strate from the cocktail fully prevented the appearance of
The Journal of Cell Biology, Volume 115, 1991
formazan precipitate. This indicates that the reduction of
NBT was dependent upon thepurine compound, and that un-
der the conditions of our histochemical reactions, there was
not a detectable level of reductase activity capable of acting
directly uponNBT. That the reaction is specific to the purine
catabolic enzymes is implied by theuse ofpharmacologic in-
hibitors. Thuswhen the complete pathway was assayed using
AMP, the preincubation of the tissue with dCF, a potent in-
hibitor ofADA, or with oxypurinol, the active metabolite of
the clinically potent XO inhibitor allopurinol (for review,
Rundles, 1985), there was complete inhibition of formazan
appearance (Fig. 4, E and F, respectively) . These results
strongly support the specificity of the histochemical reac-
tions, and taken with the results described above, indicate
that the entire set of purine catabolic enzymes function to-
gether in situ .
Coordinate Regulation ofPurine CatabolicEnzyme
Expression during PostnatalGI TractDevelopment
Because ADA activity has been noted to increase progres-
sively in the proximal mouse GI tract over the first 1-3 wk
after birth (Lee, 1973 ; Chinsky, 1990) and immediately after
implantation in the reproductive tract (Knudsen et al ., 1988 ;
184Table L Summary ofHistochemical Analyses
7-d-old pup
Tongue
￿
Surface epithelial
￿
+
Duodenum
￿
Villous epithelial
￿
+
3-d-old pup
Tongue
￿
Weak signals,
￿
+
surface epithelial
Duodenum
￿
Weak signals,
￿
+
villous epithelial
1-d-old pup
Tongue
￿
Trace signals,
￿
tr.
surface epithelial
Duodenum
￿
Trace signals,
￿
tr.
villous epithelial
Summary of histochemical staining reactions performed for each of the purine catabolic enzyme activities as described in Figure 3. Visual assessment of each
enzyme reaction was made and recorded as trace (tr) when just visible; +, light staining; and ++, dark staining.
ourselves, unpublished), we evaluated histologically whether
the expression of each ofthe other purine catabolic enzymes
increased in parallel. In the GI tract, as summarized in
Table I, term fetal duodenum (-day 19.5 p.c.) failed to ex-
press any of the purine catabolic enzymes (see also Fig. 4
G). However, even 1 day following birth, the histochemical
staining technique demonstrated faintly detectable SNT,
ADA, and PNP in the duodenum. XO, however, was not de-
tected until day 3. By postnatal day 7, however, each of the
purine catabolic enzymes was present at low yet easily de-
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Histochemically tested enzyme activities
ADA PNP XO GUAase AMP-XO
tr.
￿
tr.
￿
-
￿
tr.
tr.
￿
tr.
￿
-
￿
tr.
tectable levels within the same cell types of tongue and
duodenum (see also Fig. 4 H) . These results are fully consis-
tent with the results reported by Lee (1973) in which there
were parallel increases in the specific activity of several of
these enzymes in crude homogenates over the first several
weeks after birth. Since our results indicate that there are
also increases in the activities of SNT, PNP, and GUAase,
we conclude that each of the purine catabolic pathway en-
zymes is subject to postnatal developmental activation in a
coordinated manner.
Term-fetal pup
Tongue
Duodenum
No signals
No signals
Human GI tissues
Tongue No signals -
Esophagus No signals -
Duodenum Villous enterocytes; ++
brush border and
basalar
Mouse
Reproductive tract
Day 7 Circumferential + +
periembryonic
decidual cells
Day 9 Antimesometrial + +
decidual cells
Day 16 Decidua basalis cells + +
and spongiocyto-
trophoblasts
Tissue
Mouse GI tract
adult
Tongue
Location of enzyme activity S NT/AP
Mature squamous
Esophagus mucosal epithelial + +
cells
Forestomach
Duodenum Mature villous ++
enterocytes: brush
border and basalarMouse versusHuman GI Tract
We have previously shown a distinction between humans and
mice in that unlike mice, extracts of tongue and esophagus
from humans express ADA at only a low level (Aronow et
al., 1989) . To evaluate whether the expression of the other
catabolic enzymes was also limited to the duodenum, we ap-
plied the histochemical stains to cross-sections of human
tongue and esophagus . No signal was detected for any of the
enzymes (Table I) . In contrast, terminal villous epithelial
cells of the human duodenum did coexpress all of the en-
zymes of the purine catabolic pathway (Table I, and Fig . 4
J) . Thus, while the tissues that express purine catabolic en-
zymes within the GI tract are not conserved between mice
and humans, coregulation of the entire pathway is conserved
in the duodenum .
Subcellular Localization ofEach Purine Catabolic
Enzyme in the Duodenal Brush Border
In the duodenum, for each enzyme and for the entire purine
catabolic pathway, formazan reaction product was not depos-
ited uniformly over the entire cell body of the terminally
differentiated epithelial cells . Rather, deposition occurred
most intensely over the brush border/apical portion ofthe en-
terocyte, with a less intense accumulation of product occur-
ring in the basalar aspect ofthe enterocyte next to the lamina
propria . A similar staining pattern was observed for each of
the enzymes in both mouse and human enterocytes although
perhaps the ratio ofapical to basalar staining varied depend-
ing on the specific enzyme (Fig. 4, I-K, others not shown) .
Compared to the apically stained portion ofmouse duodenal
enterocytes, apical staining in human duodenal enterocytes
was more obviously restricted to a tight brush border band .
The basis for this difference is not clear at this time . The
diffuseness of the staining reaction is attributable at least in
part to high activity of the enzymes with rapid deposition of
formazan . Shorter incubations and inspection ofenterocytes
nearer to the base ofthe villi show more apparent restriction
to the brush border (Fig . 4 K) .
Coordinate Expression ofPurine Catabolic
Enzyme Expression during thePbstimplantation
Maternal Decidual Reaction
Each of the purine catabolic enzymes also was expressed in-
tensely by a series of distinct cell types of the uterus and
placenta during the postimplantation maternal decidual
reaction (days 6.5-9) and as well in the maturing placenta
(days 11-18) (Fig. 4, L-N) . The only exception to this state-
ment is that GUAase activity was not detectable at any of
these stages . At an early postimplantation stage (-day 6.5
p.c.), each of the enzymes of the purine catabolic pathway
exhibited strong expression and colocalization in a subset of
maternal decidual cells immediately surrounding the embryo
(Fig . 4 L; Table I) . In contrast, decidual cells further from
the embryo failed to express the purine catabolic enzymes
at a detectable level . By examination of an adjacent section
stained with hematoxylin and eosin (Fig . 4 M), it is apparent
that among the positively stained decidual cells are many
with fragmented and pyknotic nuclei and occasional cyto-
plasmic vacuolation . At the next stage that we have studied
in detail, day 9 p.c., there is a very high level of expression
of the purine catabolic enzymes within the maternal an-
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Figure 5. HPLC analysis of purine metabolites generated from in-
cubation of AMP with mouse duodenum . Mouse duodenum was
opened lengthwise and cut into squares (N50 mg each) and placed
into 1 ml of 1 mM AMP at 37°C as described in experimental
procedures . At the indicated times, aliquots were removed, acid ex-
tracted, neutralized, and analyzed byHPLC to identify each purine
metabolite . The amount of accumulated metabolite is indicated in
the z-axis for each time point . Samples incubated in the presence
ofdCF and Hpp show accumulations of adenosine and hypoxan-
thine, respectively. Note that adenosine is never accumulated in the
absence of dCF. Asterisk (*) indicates that hypoxanthine, xanthine,
and UA could not be quantitated from incubations that included
dCF because of the presence of low-abundance unidentified com-
pounds with overlapping retention times . Most likely, these com-
pounds represent acid hydrolysis products ofdCF.
timesometrial decidual cells (decidua capsularis shown in
Fig . 3 H), a population of cells that has been characterized
to be in a stage of degeneration and regression (Welsh and
Enders, 1985 ; Katz and Abrahamsohn, 1987) . Except for
their anatomic location, these cells appear morphologically
identical to the periembryonic decidual cells at day 6.5 p.c. .
Nearer to term (day 16 p.c.), a major zone of the placenta
that is immediately adjacent to the myometrium was strik-
ingly positive for ADA mRNA as assessed by in situ hybrid-
ization (Fig . 3, H-J, and the purine catabolic enzymes (Table
I ; Fig. 4M, others not shown) . Three subzones can be recog-
nized : a layer containing fetal spongiotrophoblasts, maternal
decidual basalis cells, and maternal derived metrial gland
cells (Stewart and Peel, 1978) . There may be some differ-
ences among these cell types with respect to their quantita-
tive expression of each purine catabolic enzyme, but the
histochemical method is not sufficiently quantitative or of
sufficient resolution to be sure. What is clear however, is that
each enzyme is expressed by the predominant cell type of
each zone at much higher levels than surrounding placental
cell types (Fig . 4 N) .
Analysis ofPurine MetabolitesbyHPLC
As further proof that the histochemical observations were
186representative of authentic purine catabolism, analyses of
purine metabolites were carried out by HPLC. To do this,
small fragments of intact duodenum were incubated with
AMP in solution. As indicated in Fig. 5, all of the expected
catabolites ofAMP accumulated in the incubation medium,
except for adenosine. However, adenosine did accumulate
when a tissue fragment was first preincubated with 2' de-
oxycoformycin (dCF). Similarly, dCF treatment strongly
interfered with the accumulation of Ino. Preincubation of
duodenum with allopurinol caused the accumulation of hy-
poxanthine and inosine, and no accumulation of xanthine or
UA. Since adenosine did not appear in the medium in the ab-
sence of dCF, it is likely that AMP dephosphorylation and
ADA-mediated conversion of adenosine to inosine are nor-
mally quite tightly coupled at the duodenal brush border.
The accumulation of inosine and each of the nucleobases in
the incubation medium that occurred in the absence of the
inhibitors suggests that the metabolic conversions that follow
ADA may not be as stringently coupled in situ as assayed un-
der our conditions. Incubation of human duodenum with
AMP gave similar results with no adenosine accumulation.
These results confirm that the GI tract has the capability of
catabolizing purines at high level (see introduction) and
demonstrate that the histochemical staining reactions are
specific for these metabolic reactions.
Discussion
Multilevel Coordination ofPurine Catabolic
Enzyme Expression
These studies have indicated that there is a high levelofcoor-
dination in the expression ofpurine catabolic enzymes along
the proximal mouse GI tract, and in the postimplantation
reproductive tract. This occurs at several distinct levels.
First, each of the enzymes comprising the complete meta-
bolic pathway is expressed together at high level in distinct
and structurally diverse tissues of the proximal GI tract:
tongue, esophagus, forestomach, and duodenum. This con-
cordance extends in a cell type-specific manner: in each cell
type with high level expression of one of the enzymes, there
is also high-level expression of each of the other enzymes.
Moreover, in each tissue location, there is lumenal coordina-
tion such that expressionofthe metabolic pathway is directed
at or very near to the lumenal surface of the proximal GI
tract. Second, within each tissue type, the expressionof each
enzyme occurs only in cells that are in the process of under-
going a postmitotic differentiation program. This pattern is
matched by the in situ hybridization results obtained for the
presence of ADA mRNA. Third, during postnatal GI tract
maturation, there is an indistinguishable time course over
which each enzyme becomes highly expressed. Finally, in
the reproductive tract, except for GUAase, each of the en-
zymes is coexpressed by a subset of mouse maternal decidua
cells that are undergoing a rapid program of postimplanta-
tion development and are potentially at an early stage of
regression and/or programmed cell death (see below) .
Subcellular Localization ofPurine Catabolic
Enzymes in the Duodenum
The histochemical assays, despite their somewhat limited
histological resolution, suggest that there is a strong degree
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of localization ofthe purine catabolic enzymes to the apical
and/or brush border membrane of the duodenal enterocyte
in adult mice and humans. It is important to note that while
NBT reduction exhibits an effective signal, its ability to sub-
localize the signal to membrane versus cytoplasmic seg-
ments of the expressing cell types is limited. In results not
shown, antibody localization of ADA in the mouse duode-
num provides an identical signal, highly predominant in the
brush border. Immunohistochemical localization of the
other enzymes remains to be done. Brush border localization
has been reported for a wide variety of digestive enzymes
such as disaccharidases and aminopeptidases. However, the
mechanism(s) for localizing (what are normally) cytoplas-
mic and/or soluble enzymes (ADA, PNP, GUAase, XO) are
not clear. Chicken gizzard 5NT, extracellularly localized,
has been shown to have the capability of direct carboxyl ter-
minal interaction with laminin and fibronectin (Stochaj et
al., 1989). That ADA is easily releasable from its duodenal
localization is suggested by its specific activity in soluble ex-
tracts as shown in Fig. 2 . Several mechanisms by which ex-
tracellular proteins are localized to the brush border, such
as covalent linkage to phophatidyl inositol, have been dis-
cussed by Semenza (1989). Other means of localization
could involve interactions with specific binding proteins
such as the ADA complexing protein (Schrader and West,
1990). In fact, Dinjens et al. (1989) have shown that im-
muno-cross-reactive ADA complexing protein is precisely
localized to the apical enterocyte brush border membrane in
mice and humans. Interestingly, the complexing protein is
also expressed in other cell types such as the proximal tubu-
lar epithelium of kidney, but the form isolated from kidney
does not bind ADA, nor is ADA expressed at high level in
these cells.
Physiological Significance ofHigh-Level
Purine Degradation?
The deamination of adenosine or deoxyadenosine by ADA
could be essential for regulating local concentrations of Ado.
This couldbe important ifAdo were to act as a neurotrans-
mitter in these tissues (Nagy et al., 1984; Norstrand, 1985;
Yamamoto et al., 1987; Williams, 1987), or if resident cell
types such as intra-epithelial lymphocytes were unable to
function in regions with high concentrations of these pu-
rines. Also, high-level ADA expression could be part of a
metabolic pathway leading either to the net salvage of pre-
formed purines or the net breakdown to nonreusable com-
pounds. Since our results have shown that high-level ADA
expression is accompanied by high-level expression of each
of the other purine catabolic enzymes, including xanthine
oxidase, the general implication of these results is that there
appears to be a commitment by the above described cell
types to the digestion and degradation of purine nucleotides.
It is likely that there are common regulatory mechanisms
that control the expressionofthese enzymes, but this remains
to be determined. Perhaps a clue for the future is that since
GUAase expression is separable from the expression of the
other enzymes in the reproductive tract, the regulatory fac-
tors directing gene expression in the female reproductive
tract cannot be the same as those in the proximal GI tract.
Italso certainly remains to be determined what the biological
significance is of this elaborately organized expression pat-
tern, but a variety of evidence from several sources suggests
187several considerations. Since epithelialcellsofcolon, cervix,
and other types of mucosae differentiate and mature in a
manner similar to the epithelial cellsof the proximal GI tract
but do not exhibit focal high-level expression of ADA, high
level ADA expression in the proximal GI tract must have
some local significance and not be related to the mechanism
of epithelial cell differentiation per se. Similarly, only a se-
lect population of decidual cellsof the gravid uterus exhibits
high level ADA expression. Therefore, high-level ADA ex-
pression in the proximal GI tractand restricted cell types of
the placenta is most likely related to specific local inductive
influences, and perhaps, to the function of the enzyme in
these locations. Several of these potential functions will be
discussed briefly in turn.
GI Tract Expression
Despite the evolutionary conservation of GI tract purine
degradation in mice and humans, there is little evidence for
abnormal GI tract function in humans with three different
gene defects affecting purine catabolism. ADA-deficient
children fail to develop the immune system, buthave remark-
ably little other pathology (Giblett et al., 1972; Hirschhorn
et al., 1981; and for reviews Carrera and Carson, 1987;
Kredich and Hershfield, 1989) . For example, ADAdeficient
children do not exhibit striking abnormality ofGI tractfunc-
tion after a bone marrow transplantation that has restored
immune function (Kredich and Hershfield, 1989) . Thus, it
is unlikely that low concentrations of free adenosine must be
maintained locally for the basic functioning (e.g., peristalsis
or circulatory control) ofthe GI tract. Further, PNP-deficient
children do not exhibit any striking abnormalities of GI tract
function, and finally, clinically normal adult humans have
been found with apparently complete deficiency of XO (for
review see Holmes and Wyngaarden, 1989) . Thus, whatever
physiological role is played by GI tractexpression ofthe com-
plete purine catabolic pathway, a failure to do so is not a
cause of marked GI tract dysfunction per se. An additional
consideration is the suggestion that nucleotides may be semi-
essential nutrients (for review, see Uauy, 1989) . Specifically,
young mice fed a nucleoside-free diet show a significant
decrease in their ability to survive sepsis (Kulkarni et al.,
1986a,b), exhibit delayed allograft rejection (Van Buren et
al., 1985), and have striking alterations in their fecal bacte-
rial flora (Gil et al., 1986). The addition of nucleic acids to
nucleoside-free chow at least partly reverses these effects.
However, in lightofthe high levelofpurine catabolism in the
proximal GI tract, it would seem paradoxical to suppose that
exogenous purine nucleotides were nutritionally significant.
An alternate consideration might be that the in situ degra-
dation ofnucleotides could itselfbe ofbenefit to the gastroin-
testinal microenvironment. Such couldbe the case ifthe deg-
radation of reutilizable purine was inhibitory to the growth
of some microorganisms. For example, parasitic protozoa,
causative agents of a plethora of humandiseases, are entirely
auxotrophic for purines and contain powerful mechanisms
for purine salvage (Aronow et al ., 1986). Since the GI tract
is a frequent target site in the life cycles of a variety of para-
sites, such as Toxoplasma, Entamoeba, Giardia, and Hel-
minthic organisms, it is possible that the in situ degradation
of purines has served as an evolutionarily significant line of
defense against parasitism.
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Reproductive Tract Expression
As described in Results, there is high-level expression of pu-
rine degradative enzymes in an intricate series of locations
within the expanding implantation chamber and the develop-
ing placenta during mouse pregnancy. Despite the diverse lo-
cations in which the catabolic enzymes are expressed, the
actual number of different cell types may be rather limited.
During the first half of pregnancy, the major expressing cell
types are a subset of maternal decidual cells previously
known to express high levels of alkaline phosphatase and
SNT (Hall, 1971; Finn, 1971), and more recently ADA
(Knudsen et al., 1988, 1991). The maternal decidualization
reaction is the result of the proliferation and differentiation
ofuterine stromal cells (Loeb, 1908; Krehbiel, 1937; Enders
et al ., 1985), and represents a major portion of the overall
growth that occurs during the first half of postimplantation
pregnancy in the mouse (Rugh, 1968; Theiler, 1972). The
decidual reaction can be divided into two phases. In the first
(days 6-7), there is a concentric proliferative development of
decidual cells extending from the embryo to the myometri-
um. However, only the small fraction ofthe resultant decidual
cells that are immediately adjacent to the embryo express the
purine catabolic enzymes. In the second phase (days 8-10),
there is intense regression of the antimesometrial decidua
capsularis cells (Welsh and Enders, 1985; Katz and Abra-
hamson, 1987), and these are quite uniformly positive for
high level expression of the purine catabolic enzymes. By
colcemid arrest and radiolabeled thymidine incorporation,
Finn and Martin (1967) have shown that unlike the surround-
ing decidual cells, those from these two regions in which we
see purine catabolic enzyme expression consist of non- or
postmitotic cells. Thus the nonmitotic cells, which are
clearly in the process of regression, appear to express the pu-
rine catabolic enzymes as a gene regulatory event that pre-
cedes their undergoing programmed cell death . The excep-
tion to this is that GUAase was not expressed by any of the
cell types in the reproductive tract. Consistent with the lack
of guanase expression by the decidual cell types, and our
proposal that the role of the catabolic enzymes is to metabo-
lize large quantities of nucleosides generated in situ, Van
Kveel (1982) has observed that both uric acid and guanine
accumulate in amniotic fluid. Expressionof the catabolic en-
zymes may be especially critical in the early postimplanta-
tion period as Knudsen et al. (1989) have shown that the inhi-
bition of ADA activity at day 7 or 8 p.c., but not at day 6
or 9 causes pronounced embryolethality with neural plate
cell degeneration. Also, the administration ofallopurinol to
day 9 p.c. mice has also been reported to result in a signifi-
cant degree of fetal loss and teratogenicity (Fujii and Nishi-
mura, 1972) .
The final stages of implantation chamber development are
somewhat more difficult to understand in the context of the
purine catabolic enzyme expression. From day 11 through
term, the labyrinth zone of the chorioallantoic placenta,
composed chiefly of fetal trophoblastic cells, is organizing
and expanding into the maternal decidua basalis along the
mesometrial side ofthe uterus. During this phase, the mater-
nal decidua basalis that underlies this region undergoes a
prominent and continuous regression (Stewart and Peel,
1978) . Consistent with earlier stages, the regressing decidual
cells exhibit intense expression of the purine catabolic en-
188zymes. Further, only a subset of the decidual cells in the
basalis are positive. One or two days prior to term, the de-
cidua basalis layer has become quite thin, but it is virtually
completelypositive for the purine catabolic enzymes. At this
stage, there is also purine catabolic enzyme expression by
a subpopulation of fetal-derived cells of the placenta (spon-
giotrophoblasts) that are interposed between the embryo-de-
rived chorioallantoic plate and the maternal-derived decidua
basalis (Fig. 3,1 and J). Consistent with this, Knudsen et al.
(1991) have shown by adoptive transfer of embryos that un-
like days 7-11 p.c., ADA expressionat day 13 occurs in both
materna and fetal derived cell types. These cells may play
an additional role in the protection of the embryo from the
potentially cytotoxic effects of high concentrations of purine
nucleotides such as adenosine and deoxyadenosine released
by regressing cells undergoing programmed cell death.
Decidual cells have been long considered to play a role in
the nutrition of the early postimplantation embryo, but given
the high level of XO expression by the periembryonic
decidual cells, it is unlikely that decidual cell degeneration
leads to the production of preformed and nontoxic purines
for the rapidly proliferating cellsofthe embryo. More likely,
the purine catabolic enzymes are expressed to cope with a
considerable amount ofpurine nucleotides that are generated
by a high level of cell death that accompanies remodeling of
the maternal decidua (Welsh and Enders, 1985 ; Katz and
Abrahamson, 1987). Sinceinduction of the purine catabolic
enzymes precedes and accompanies programmed cell death
in these tissues, we hypothesize that before actual cell death,
there is induced expression of enzymes to detoxify cellular
breakdown products. Thus, a segment of the cell death pro-
gram may be directed towards the expression ofcatabolic en-
zymes. In this manner, tissues undergoing programmed cell
death may share some of the characteristics of tissues dedi-
cated to digestive metabolism such as the proximal GI tract.
This "concerted catabolic clean-up hypothesis" suggests that
in the process ofmarking a cell for death, some of the genes
that must be activated are those that are necessary for the me-
tabolism of potentially toxic or bioactive compounds re-
leased by cellular autolysis. A partly analogous situation
could be imagined in the thymus. Regulatory elements that
direct high level ADA expressionin humanthymus (Aronow
et al ., 1989) could also be a response or adaptation to the
occurrence of programmed cell death among thymocytes
marked for cell death. However, unlike the proximal GI and
the maternal fetal interface, in the thymus there is discoor-
dinate expression ofADA and PNP in separate cell-type sub-
populations (Barton et al ., 1980; Ma et al., 1982; ourselves
unpublished), and there is no detectable xanthine oxidase
activity in the thymus (Aronow, B., and D. Witte, unpub-
lished) . Thus nontoxic purines may be salvaged by rapidly
proliferating thymocytes. In contrast, preformed purines are
less likely to be salvaged by the embryo because uric acid
is not reusable. But similar to intrathymic T cell develop-
ment, the rapid development of the maternal-fetal interface
may also require a high level ofprogrammed cell death and
therefore the need for purine catabolic enzyme expression.
It is possible that a failure to express this or any of several
catabolic pathways during implantation, placental, and em-
bryonic development could lead to infertility, intrauterine
growth retardation, birth defects, or fetal death.
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